Physical and chemical insults induce inflammation and gastrointestinal cancers

Cancer Letters

Volumn 345, Issue 2, 2014, Pages 190-195

  Wilson, George S ^a   George, Jacob ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Chemical; Gastrointestinal; Inflammation; Physical

Indexed keywords

ACETYLSALICYLIC ACID; TOXIC SUBSTANCE;

ALCOHOL CONSUMPTION; BACTERIAL INFECTION; BEVERAGE; CANCER RISK; CARCINOGENESIS; CHEMICAL INSULT; CHRONIC INFLAMMATION; COLON CANCER; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE COURSE; ESOPHAGUS CANCER; GALLBLADDER CANCER; HEPATITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVER CANCER; LIVER CELL CARCINOMA; NONHUMAN; PANCREAS CANCER; PATHOPHYSIOLOGY; PHYSICAL INSULT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SMOKING; STOMACH CANCER; VIRUS INFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); NICOTIANA TABACUM;

CANCER; CHEMICAL; GASTROINTESTINAL; INFLAMMATION; PHYSICAL;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATION; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION; WOUNDS AND INJURIES;

EID: 84896708986     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.07.011     Document Type: Review

References (87)

1. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
2. Macarthur M., Hold G.L., El-Omar E.M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. American Journal of Physiology Gastrointestinal and Liver Physiology 2004, 286:G515-G520.
3. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Molecular Cancer Research 2006, 4:221-233.
4. Ohshima H., Tatemichi M., Sawa T. Chemical basis of inflammation-induced carcinogenesis. Archives of Biochemistry and Biophysics 2003, 417:3-11.
5. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
6. Moore M.M., Chua W., Charles K.A., Clarke S.J. Inflammation and cancer: causes and consequences. Clinical Pharmacology and Therapeutics 2010, 87:504-508.
7. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nature Reviews 2003, 3:276-285.
8. Liu E.S.-L., Ye Y.-N., Shin V.Y., Yuen S.-T., Leung S.-Y., Wong B.C.Y., Cho C.-H. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003, 24:1407-1413.
9. Trichopoulos D., Day N.E., Kaklamani E., Tzonou A., Munoz N., Zavitsanos X., Koumantaki Y., Trichopoulou A. Hepatitis B virus, tobacco smoking and ethanol consumtion in the etiology of hepatocellular carcinoma. International Journal of Cancer 1987, 39:45-49.
10. Wang L.-Y., You S.-L., Lu S.-N., Ho H.-C., Wu M.-H., Sun C.-A., Yang H.-I., C.C.-J. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes and Control 2003, 14:241-250.
11. Ye Y.-N., Liu E.S.-L., Shin V.Y., Wu W.K.-K., Cho C.-H. Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. Toxicology 2004, 203:179-188.
12. Castellsague X., Munoz N., De Stefani E., Victora C.G., Castelletto R., Rolon P.A. Influence of Mate drinking, hot beverages and diet on esophageal cancer risk in South America. International Journal of Cancer 2000, 88:658-664.
13. Kubo N., Furusyo N., Nakashima H., Kashiwagi K., Hayashi J. Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia. European Journal of Epidemiology 2005, 20:251-261.
14. Victora C.G., Munoz N., Day N.E., Barcelos L.B., Peccin D.A., Braga N.M. Hot beverages and oesophageal cancer in Southern Brazil: a case control study. International Journal of Cancer 1987, 39:710-716.
15. Ohshima H., Tazawa H., Sylla B.S., Sawa T. Prevention of human cancer by modulation of chronic inflammatory processes. Mutation Research 2005, 591:110-122.
16. Farrow B., Evers B.M. Inflammation and the development of pancreatic cancer. Surgical Oncology 2002, 10:153-169.
17. Berasain C., Castillo J., Perugorria M.J., Latasa M.U., Prieto J., Avila M.A. Inflammation and liver cancer: new molecular links. Steroid Enzymes and Cancer 2009, 1155:206-221.
18. Buttar N.S., Wang K.K., Leontovich O., Westcott J.Y., Pacifico R.J., Anderson M.A., Krishnadath K.K., Lutzke L.S., Burgart L.J. Chemoprevention of Esophageal Adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's Esophagus. Gastroenterology 2002, 122:1101-1112.
19. Roa I., Aretxabala X.D., Araya J.C., Roa J. Preneoplastic lesions in Gallbladder cancer. Journal of Surgical Oncology 2006, 93:615-623.
20. Wang D., DuBois R.N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010, 29:781-788.
21. Wistuba I.I., Gazdar A.F. Gallbladder cancer: lessons from a rare tumour. Nature Reviews 2004, 4:695-706.
22. Westbrook A.M., Szakmary A., Schiestl R.H. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutation Research/Reviews in Mutation Research 2010, 705:40-59.
23. Elgbratt K., Bjursten M., Willén R., Bland P.W., Hörnquist E.H. Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone G?i2-deficient mice. Immunology 2007, 122:199-209.
24. Huang T.T., Zong Y., Dalwadi H., Chung C., Miceli M.C., Spicher K., Birnbaumer L., Braun J., Aranda R. TCR-mediated hyper-responsiveness of autoimmune Gαi2-/-mice is an intrinsic naïve CD4+ T cell disorder selective for the Gαi2 subunit. International Immunology 2003, 15:1359-1367.
25. Rudolph U., Finegold M.J., Rich S.S., Harriman G.R., Srinivasan Y., Brabet P., Boulay G., Bradley A., Birnbaumer L. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nature Genetics 1995, 10:143-150.
26. Castellsague X., Munoz N., De Stefani E., Victoria C.G., Castelletto R., Rolon P.A., Quintana M.J. Independant and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. International Journal of Cancer 1999, 82:657-664.
27. Enzinger P.C., Mayer R.J. Esophageal Cancer. The New England Journal of Medicine 2003, 349:2241-2252.
28. Gao Y.-T., McLaughlin J.K., Blot W.J., Ji B.-T., Benichou J., Dai Q., Fraumeni J.F. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. International Journal of Cancer 1994, 58:192-196.
29. Freedman N.D., Abnet C.C., Leitzmann M.F., Mouw T., Subar A.F., Hollenbeck A.R., Schatzkin A. A prospective study of tobacco, alcohol, and the risk of Esophageal and gastric cancer subtypes. American Journal of Epidemiology 2007, 165:1424-1433.
30. Kamangar F., Strickland P.T., Pourshams A., Malekzadeh R., Boffetta P., Roth M.J., Abnet C.C., Saadatian-Elahi M., Rakhshani N., Brennan P., Etemadi A., Dawsey S.M. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of Esophageal cancer in Northeastern Iran. Anticancer Research 2005, 25:425-428.
31. Ghadirian P. Thermal irritation and Esophageal cancer in Northern Iran. Cancer 1987, 60:1909-1914.
32. Segi M. Tea-gruel as a possible factor for cancer for the esophagus. Gann 1975, 66:199-202.
33. Ghadirian P., Ekoe J.M., Thuouez J.P. Food habits and esophageal cancer: an overview. Cancer Detective Prevention 1992, 16:163-168.
34. O'Neill C.H., Hodges G.M., Riddle P.N., Jordan P.W., Newman R.H., Flood R.J., Toulson E.C. A fine fibrous silica contaminant of flour in the high oesophageal cancer area of north-east Iran. International Journal of Cancer 1980, 26:617-628.
35. Zaridze D., Borisova E., Maximovitch D., Chkhikvadze V. Alcohol consumption, smoking and risk of gastric cancer: case-control study from Moscow, Russia. Cancer Causes and Control 2000, 11:363-371.
36. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., Biserni R., Cipriani F., Cocco P., Giacosa A., Marubini E., Puntoni R., Vindigni C., Fraumeni J.F., Blot W. A case-control study of gastric cancer and diet in Italy. International Journal of Cancer 1989, 44:611-616.
37. De Stefani E., Correa P., Boffetta P., Deneo-Pellegrini H., Ronco A.L. Mendilaharsu, dietary patterns and risk of gastric cancer: a case-control study in Uruguay. Gastric cancer 2004, 7:211-220.
38. Pourfarzi F., Whelan A., Kaldor J., Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran-a population based study. International Journal of Cancer 2009, 125:1953-1960.
39. Joossens J.V., Hill M.J., Elliott P., Stamler R., Stamler J., Lesaffre E., Dyer A., Nichols R., Kesteloot H. Dietary salt, nitrate and stomach cancer mortality in 24 countries. International Journal of Epidemiology 1996, 25:494-504.
40. Cocco P., Palli D., Buiatti E., Cipriani F., DeCarli A., Manca P., Ward M.H., Blot W.J., Fraumeni J.F. Occupational exposures as risk factors for gastric cancer in Italy. Cancer Causes and Control 1994, 5:241-248.
41. Kelley J.R., Duggan J.M. Gastric cancer epidemiology and risk factors. Journal of Clinical Epidemiology 2003, 56:1-9.
42. Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutation Research 1995, 339:73-89.
43. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Research 1994, 305:253-264.
44. Boeing H., Frentzel-Beyme R., Berger M., Berndt V., Gores W., Korner M., Lohmeier R., Menarcher A., Mannl H.F.K., Meinhardt M., Muller R., Ostermeier H., Paul F., Schwemmle K., Wagner K.H., Wahrendorf J. Case-control study on stomach cancer in Germany. International Journal of Cancer 1991, 47:858-864.
45. Mosavi-Jarrahi A., Mohagheghi M.A. Epidemiology of Esophageal cancer in the high-risk population of Iran. Asian Pacific Journal of Cancer Prevention 2006, 7:375-380.
46. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
47. Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. Journal of Hepatology 2008, 48:380-381.
48. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology 2006, 24:2137-2150.
49. Qian G.S., Ross R.K., Yu M.C., Yuan J.-M., Gao Y.-T., Henderson B.E., Wogan G.N., Groopman J.D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai. People's Republic of China Cancer Epidemiol Biomarkers Prevention 1994, 3:3-10.
50. Yu M.C., Yuan J.-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004, 127:S72-S78.
51. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K.H., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependant IL-6 production. Science 2007, 317:121-124.
52. Schmahl D., Habs M., Ivankovic S. Carcinogenesis of N-Nitrosodiethylamine (DENA) in chickens and domestic cats. International Journal of Cancer 1978, 22:552-557.
53. Sheth S., Bedford A., Chopra S. Primary Gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. The American Journal of Gastroenterology 2000, 95:1402-1410.
54. Shukla V.K., Prakash A., Tripathi B.D., Reddy D.C.S., Singh S. Biliary heavy metal concentrations in carcinoma of the gall bladder: casecontrol study. BMJ 1998, 317:1288-1289.
55. Ojajarvi I.A., Partanen T.J., Ahlbom A., Boffetta P., Hakulinen T., Jourenkova N., Kauppinen T.P., Kogevinas M., Porta M., Vainio H.U., Weiderpass E., Wesseling C.H. Occupational exposures and pancreatic cancer: a meta-analysis. Occupation Environmental Medicines 2000, 57:316-324.
56. Farrow D.C., Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. International Journal of Cancer 1990, 45:816-820.
57. Gandini S., Botteri E., Iodice S., Boniol M., Lowenfels A.B., Maisonneuve P., Boyle P. Tobacco smoking and cancer: a meta-analysis. International Journal of Cancer 2008, 122:155-164.
58. Iodice S., Maisonneuve G.S.P., Lowenfels A.B. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Archives of Surgery 2008, 393:535-545.
59. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., Dimagno E.P., Andren-Sandberg A., Domellof L. Pancreatitis and the risk of pancreatic cancer. New England Journal of Medicine 1993, 328:1433-1437.
60. Michaud D.S., Giovannucci E., Willet W.C., Colditz G.A., Fuchs C.S. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States Cohorts1. Cancer Epidemiol Biomarkers Prevention 2001, 10:429-437.
61. Chao A., Thun M.J., Jacobs E.J., Henley S.J., Rodriguez C., Calle E.E. Cigarette smoking and Colorectal cancer mortality in the cancer prevention study II. Journal of the National Cancer Institute 2000, 92:1888-1896.
62. Cho E., Smith-Warner S.A., Ritz J., van den Brandt P.A., Colditz G.A., Folsom A.R., Freudenhelm J.L., Glovannucci E., Goldbohm A., Graham S., Holmberg L., Kim D.-H., Malila N., Miller A.B., Pletinin P., Rohan T.E., Sellers T.A., Spelzer F.E., Willet W.C., Wolk A., Hunter D.J. Alcohol intake and Colorectal cancer: a pooled analysis of 8 cohort studies. Annals of International Medicine 2004, 140:603-613.
63. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of Colorectal cancer. Cancer Epidemiology Biomarkers Prevention 2001, 10:725-731.
64. Marchand L.L., Wilkens L.R., Kolonel L.N., Hankin J.H., Lyu L.-C. Associations of sedentary lifestyle, obesity, smoking, alcohol use and diabetes with risk of colorectal cancer. Cancer Research 1997, 57:4787-4794.
65. Otani T., Iwasaki M., Yamamoto S., Sobue T., Hanaoka T., Inoue M., Tsugane S. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese Men and women: Japan public health center-based prospective study. Cancer Epidemiology, Biomarkers and Prevention 2003, 12:1492-1500.
66. Samad A.K.A., Taylor R.S., Marshall T., Chapman M.A.S. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Disease 2005, 7:204-213.
67. Wolin K.Y., Yan Y., Colditz G.A., Lee I.-M. Physical activity and colon cancer prevention: a meta-analysis. British Journal of Cancer 2009, 100:611-616.
68. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2003, 18:1-5.
69. Thun M.J., Namboodiri M.M., Heath C.W. Aspirin use and reduced risk of fatal colon cancer. The New England Journal of Medicine 1991, 325:1593-1596.
70. Okayasu I., Ohkusa T., Kajiura K., Kanno J., Sakamoto Y. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996, 39:87-92.
71. Mori H., Ohbayashi F., Hirono I., Shimada T., Williams G.M. Absence of genotoxicity of the carcinogenic sulfated polysaccharides carrageenan and dextran sulfate in mammalian DNA repair and bacterial mutagenicity assays. Nutrition and Cancer 1985, 6:92-97.
72. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
73. Shintani N., Nakajima T., Sugiura M., Murakami K., Nakamura N., Kagitani Y., Mayumi T. Proliferative effect of dextran sulfate sodium (dss)-pulsed macrophages on T cells from mice with DSS-induced colitis and inhibition of effect by IgG. Scandinavian Journal of Immunology 1997, 46:581-586.
74. Cooper H.S., Murthy S., Kido K., Yoshitake H., Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000, 21:757-768.
75. Arita M. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proceedings of the National Academy of Sciences 2005, 102:7671-7676.
76. Neurath M.F., Fuss I., Kelsall B., Büschenfelde K.H., Strober W. Effects of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice. Annals of the New York Academy of Sciences 1996, 795:368-370.
77. Qiu B., Vallance B., Blennerhassett P., Collins S. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nature Medicine 1999, 5:1178-1182.
78. Schiechl G., Bauer B., Fuss I., Lang S.A., Moser C., Ruemmele P., Rose-John S., Neurath M.F., Geissler E.K., Schlitt H.-J. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+ CD11bhighGr1low macrophages. The Journal of Clinical Investigation 2011, 121:1692.
79. Malfertheiner P., Schutte K. Smoking-A trigger for chronic inflammation and cancer development in the pancreas. The American Journal of Gastroenterology 2006, 101:160-162.
80. Pour P., Wallcave L., Gingell R., Nagel D., Lawson T., Salmasi S., Tines S. Carcinogenic effect of N-nitroso (2-hydroxypropyl)(2-oxopropyl) amine, a postulated proximate pancreatic carcinogen in Syrian hamsters. Cancer Research 1979, 39:3828-3833.
81. Guerra C., Collado M., Navas C., Schuhmacher Alberto J., Hernández-Porras I., Cañamero M., Rodriguez-Justo M., Serrano M., Barbacid M. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011, 19:728-739.
82. Wittel U.A., Pandey K.K., Andrianifahanana M., Johansson S.L., Cullen D.M., Akhter M.P., Brand R.E., Prokopczyk B., Batra S.K. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. The American Journal of Gastroenterology 2006, 101:148-159.
83. Homann N. Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production. Addiction Biology 2001, 6:309-323.
84. Toh Y., Oki E., Ohgaki K., Sakamoto Y., Ito S., Egashira A., Saeki H., Kakeji Y., Morita M., Sakaguchi Y., Okamura T., Maehara Y. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. International Journal of Clinical Oncology 2010, 15:135-144.
85. Steevens J., Schouten L.J., Goldbohm R.A., van den Brandt P.A. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010, 59:39-48.
86. Bagnardi V., Blangiardo M., La Vecchia C., Corrao G. A meta-analysis of alcohol drinking and cancer risk. British Journal of Cancer 2001, 85:1700-1705.
87. De Stefani E., Boffetta P., Mendilaharsu M., Carzoglio J., Deneo-Pellegrini H. Dietary nitrosamines, heterocyclic amines, and risk of gastric cancer: a case-control study in Uruguay. Nutrition and Cancer 1998, 30:158-162.